Poly-4-Hydroxybutyric Acid Mesh Compares Favorably With Acellular Dermal Matrix in Tissue Expander-Based Breast Reconstruction.

Annals of plastic surgery 2020 Vol.85(S1 Suppl 1) p. S2-S7

Levy AS, Bernstein JL, Xia JJ, Otterburn DM

관련 도메인

Abstract

[BACKGROUND] Acellular dermal matrix (ADM) is commonly used during immediate expander-based breast reconstruction, with potential advantages of greater intraoperative expansion, decreased time to complete expansion, and decreased rates of capsular contracture. However, ADM is associated with increased infection rate, seroma, and subsequent reconstructive failure. Poly-4-hydroxybutyric acid (P4HB) mesh is a large pore, biosynthetic scaffold shown to fully resorb and incorporate host tissues within 18 months. We sought to compare outcomes between the use of P4HB and ADM in immediate retropectoral expander-based reconstruction.

[METHODS] One hundred ninety-two consecutive cases (107 patients) of breast reconstruction using ADM were compared with a subsequent cohort of 112 cases (62 patients) using P4HB mesh. In all patients, reconstruction was performed immediately after mastectomy by a single surgeon, and outcomes were compared between groups.

[RESULTS] Baseline characteristics were similar between the P4HB and ADM groups. Overall infection rates were lower, but not significantly with P4HB (11% vs 17%, P = 0.18). Time to drain removal was significantly lower with P4HB (15 vs 18 days, P = 0.008), although there was no difference in rates of seroma (0.9% vs 3%, P = 0.43). Similar numbers of patients underwent external beam radiation (22% vs 24%) and received chemotherapy in each group (48% vs 45%). By univariate analysis, all odds ratios were decreased with use of P4HB, including risk of major complications (0.55), seroma (0.17), infection (0.59), need for reoperation (0.78), and skin necrosis (0.77).

[CONCLUSIONS] Initial findings suggest P4HB mesh to be a safe alternative to ADM in expander-based breast reconstruction, with trends toward decreased rates of infection, seroma, and need for device removal using P4HB mesh. Although our results are limited to a small series of initial patients, P4HB mesh may be a promising novel technique to decrease complications inherent to use of ADM at a reduced material cost.

추출된 의학 개체 (NER)

유형영어 표현한국어 / 풀이UMLS CUI출처등장
재료 adm 무세포진피기질 dict 7
해부 breast 유방 dict 4
합병증 seroma 장액종 dict 4
합병증 infection 감염 dict 4
재료 acellular dermal matrix 무세포진피기질 dict 2
해부 tissues scispacy 1
해부 skin scispacy 1
합병증 skin necrosis 괴사 dict 1
합병증 capsular contracture 피막구축 dict 1
약물 Poly-4-Hydroxybutyric Acid scispacy 1
약물 [BACKGROUND] Acellular dermal matrix scispacy 1
약물 [RESULTS] scispacy 1
약물 [CONCLUSIONS] scispacy 1
질환 necrosis C0027540
Necrosis
scispacy 1
기타 capsular scispacy 1
기타 P4HB → Poly-4-hydroxybutyric acid scispacy 1
기타 patients scispacy 1

MeSH Terms

Acellular Dermis; Breast Implantation; Breast Implants; Breast Neoplasms; Humans; Hydroxybutyrates; Mammaplasty; Mastectomy; Retrospective Studies; Surgical Mesh; Tissue Expansion; Tissue Expansion Devices

🔗 함께 등장하는 도메인

이 논문이 속한 카테고리와 같은 논문에서 자주 함께 다뤄지는 카테고리들

관련 논문